{"id":48221,"date":"2025-01-29T12:05:01","date_gmt":"2025-01-29T11:05:01","guid":{"rendered":"https:\/\/adc.cat\/sin-categorizar\/cesion-gradual-de-la-comercializacion-de-algunas-insulinas-de-novo-nordisk\/"},"modified":"2025-06-02T14:18:49","modified_gmt":"2025-06-02T12:18:49","slug":"cese-gradual-de-la-comercializacion-de-algunas-insulinas-de-novo-nordisk","status":"publish","type":"post","link":"https:\/\/adc.cat\/es\/actualidad\/cese-gradual-de-la-comercializacion-de-algunas-insulinas-de-novo-nordisk\/","title":{"rendered":"Suspensi\u00f3n gradual de algunas insulinas de Novo Nordisk"},"content":{"rendered":"<p><strong>Actualizaci\u00f3n sobre el cese gradual de la comercializaci\u00f3n de insulinas de Novo Nordisk<\/strong><\/p>\n<p>Como ya inform\u00f3 la Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios (AEMPS) en octubre de 2024, la farmac\u00e9utica Novo Nordisk proceder\u00e1 al cese gradual de la comercializaci\u00f3n de varios de sus productos insul\u00ednicos entre enero de 2025 y diciembre de 2026. A lo largo de este proceso, la compa\u00f1\u00eda tambi\u00e9n ha anunciado que se incorporar\u00e1n tratamientos m\u00e1s innovadores, garantizando un suministro sostenible para los pacientes.<\/p>\n<p>En el primer trimestre de 2025, se proceder\u00e1 a la discontinuaci\u00f3n del dispositivo InnoLet\u00ae, utilizado para la administraci\u00f3n de los medicamentos Actrapid\u00ae, Mixtard\u00ae y Levemir\u00ae. M\u00e1s adelante, en el cuarto trimestre de 2025, se suspender\u00e1 la comercializaci\u00f3n de Victoza\u00ae.<\/p>\n<p>A continuaci\u00f3n, detallamos los productos y presentaciones que se comercializan en Espa\u00f1a, junto con los respectivos plazos de discontinuaci\u00f3n:<\/p>\n<p><img decoding=\"async\" class=\"alignnone size-full wp-image-48218\" src=\"https:\/\/adc.cat\/wp-content\/uploads\/2025\/01\/tabla.jpg\" alt=\"\" width=\"629\" height=\"627\" srcset=\"https:\/\/adc.cat\/wp-content\/uploads\/2025\/01\/tabla.jpg 629w, https:\/\/adc.cat\/wp-content\/uploads\/2025\/01\/tabla-480x478.jpg 480w\" sizes=\"(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) 629px, 100vw\" \/><\/p>\n<p>Para m\u00e1s informaci\u00f3n consulta el comunicado de la AEMPS <a href=\"https:\/\/adc.cat\/wp-content\/uploads\/2025\/01\/AEMPS.pdf\">aqu\u00ed<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Actualizaci\u00f3n sobre el cese gradual de la comercializaci\u00f3n de algunas insulinas de Novo Nordisk.<\/p>\n","protected":false},"author":2,"featured_media":48572,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[61],"tags":[],"class_list":["post-48221","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-actualidad"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Suspensi\u00f3n gradual de algunas insulinas de Novo Nordisk - ADC \u2013 Associaci\u00f3 de Diabetis de Catalunya<\/title>\n<meta name=\"description\" content=\"Actualizaci\u00f3n sobre el cese gradual de la comercializaci\u00f3n de algunas insulinas de Novo Nordisk.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/adc.cat\/es\/actualidad\/cese-gradual-de-la-comercializacion-de-algunas-insulinas-de-novo-nordisk\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Suspensi\u00f3n gradual de algunas insulinas de Novo Nordisk - ADC \u2013 Associaci\u00f3 de Diabetis de Catalunya\" \/>\n<meta property=\"og:description\" content=\"Actualizaci\u00f3n sobre el cese gradual de la comercializaci\u00f3n de algunas insulinas de Novo Nordisk.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/adc.cat\/es\/actualidad\/cese-gradual-de-la-comercializacion-de-algunas-insulinas-de-novo-nordisk\/\" \/>\n<meta property=\"og:site_name\" content=\"ADC \u2013 Associaci\u00f3 de Diabetis de Catalunya\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ADC.CAT\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-29T11:05:01+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-02T12:18:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/adc.cat\/wp-content\/uploads\/2025\/01\/17.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"720\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Sandra\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ADC_CAT\" \/>\n<meta name=\"twitter:site\" content=\"@ADC_CAT\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Sandra\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/adc.cat\\\/es\\\/actualidad\\\/cese-gradual-de-la-comercializacion-de-algunas-insulinas-de-novo-nordisk\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/adc.cat\\\/es\\\/actualidad\\\/cese-gradual-de-la-comercializacion-de-algunas-insulinas-de-novo-nordisk\\\/\"},\"author\":{\"name\":\"Sandra\",\"@id\":\"https:\\\/\\\/adc.cat\\\/es\\\/#\\\/schema\\\/person\\\/c3095eda6e9c2068ff66a789795e0685\"},\"headline\":\"Suspensi\u00f3n gradual de algunas insulinas de Novo Nordisk\",\"datePublished\":\"2025-01-29T11:05:01+00:00\",\"dateModified\":\"2025-06-02T12:18:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/adc.cat\\\/es\\\/actualidad\\\/cese-gradual-de-la-comercializacion-de-algunas-insulinas-de-novo-nordisk\\\/\"},\"wordCount\":169,\"publisher\":{\"@id\":\"https:\\\/\\\/adc.cat\\\/es\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/adc.cat\\\/es\\\/actualidad\\\/cese-gradual-de-la-comercializacion-de-algunas-insulinas-de-novo-nordisk\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/adc.cat\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/17.jpg\",\"articleSection\":[\"Actualidad\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/adc.cat\\\/es\\\/actualidad\\\/cese-gradual-de-la-comercializacion-de-algunas-insulinas-de-novo-nordisk\\\/\",\"url\":\"https:\\\/\\\/adc.cat\\\/es\\\/actualidad\\\/cese-gradual-de-la-comercializacion-de-algunas-insulinas-de-novo-nordisk\\\/\",\"name\":\"Suspensi\u00f3n gradual de algunas insulinas de Novo Nordisk - ADC \u2013 Associaci\u00f3 de Diabetis de Catalunya\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/adc.cat\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/adc.cat\\\/es\\\/actualidad\\\/cese-gradual-de-la-comercializacion-de-algunas-insulinas-de-novo-nordisk\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/adc.cat\\\/es\\\/actualidad\\\/cese-gradual-de-la-comercializacion-de-algunas-insulinas-de-novo-nordisk\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/adc.cat\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/17.jpg\",\"datePublished\":\"2025-01-29T11:05:01+00:00\",\"dateModified\":\"2025-06-02T12:18:49+00:00\",\"description\":\"Actualizaci\u00f3n sobre el cese gradual de la comercializaci\u00f3n de algunas insulinas de Novo Nordisk.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/adc.cat\\\/es\\\/actualidad\\\/cese-gradual-de-la-comercializacion-de-algunas-insulinas-de-novo-nordisk\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/adc.cat\\\/es\\\/actualidad\\\/cese-gradual-de-la-comercializacion-de-algunas-insulinas-de-novo-nordisk\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/adc.cat\\\/es\\\/actualidad\\\/cese-gradual-de-la-comercializacion-de-algunas-insulinas-de-novo-nordisk\\\/#primaryimage\",\"url\":\"https:\\\/\\\/adc.cat\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/17.jpg\",\"contentUrl\":\"https:\\\/\\\/adc.cat\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/17.jpg\",\"width\":1080,\"height\":720},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/adc.cat\\\/es\\\/actualidad\\\/cese-gradual-de-la-comercializacion-de-algunas-insulinas-de-novo-nordisk\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/adc.cat\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Suspensi\u00f3n gradual de algunas insulinas de Novo Nordisk\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/adc.cat\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/adc.cat\\\/es\\\/\",\"name\":\"ADC \u2013 Associaci\u00f3 de Diabetis de Catalunya\",\"description\":\"L&#039;ADC representa els pacients amb diabetis de Catalunya. Els nostres objectius: informar, aconsellar, ajudar i defensar les persones amb diabetis i promoure la sensibilitzaci\u00f3 de la resta de la societat\",\"publisher\":{\"@id\":\"https:\\\/\\\/adc.cat\\\/es\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/adc.cat\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/adc.cat\\\/es\\\/#organization\",\"name\":\"Associaci\u00f3 de Diabetis de Catalunya\",\"url\":\"https:\\\/\\\/adc.cat\\\/es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/adc.cat\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/adc.cat\\\/wp-content\\\/uploads\\\/2022\\\/01\\\/associacio_de_diabetis_catalunya.png\",\"contentUrl\":\"https:\\\/\\\/adc.cat\\\/wp-content\\\/uploads\\\/2022\\\/01\\\/associacio_de_diabetis_catalunya.png\",\"width\":512,\"height\":239,\"caption\":\"Associaci\u00f3 de Diabetis de Catalunya\"},\"image\":{\"@id\":\"https:\\\/\\\/adc.cat\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ADC.CAT\\\/\",\"https:\\\/\\\/x.com\\\/ADC_CAT\",\"https:\\\/\\\/www.instagram.com\\\/adc_cat\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/associacio-de-diabetis-de-catalunya\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UC7BiJMxG_5sHYUhMAlevAWA\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/adc.cat\\\/es\\\/#\\\/schema\\\/person\\\/c3095eda6e9c2068ff66a789795e0685\",\"name\":\"Sandra\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0a992a44e4e0c2d0d7cb96813afd74f2b3b4ba44b154a672987b5285d79bb9c0?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0a992a44e4e0c2d0d7cb96813afd74f2b3b4ba44b154a672987b5285d79bb9c0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0a992a44e4e0c2d0d7cb96813afd74f2b3b4ba44b154a672987b5285d79bb9c0?s=96&d=mm&r=g\",\"caption\":\"Sandra\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Suspensi\u00f3n gradual de algunas insulinas de Novo Nordisk - ADC \u2013 Associaci\u00f3 de Diabetis de Catalunya","description":"Actualizaci\u00f3n sobre el cese gradual de la comercializaci\u00f3n de algunas insulinas de Novo Nordisk.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/adc.cat\/es\/actualidad\/cese-gradual-de-la-comercializacion-de-algunas-insulinas-de-novo-nordisk\/","og_locale":"es_ES","og_type":"article","og_title":"Suspensi\u00f3n gradual de algunas insulinas de Novo Nordisk - ADC \u2013 Associaci\u00f3 de Diabetis de Catalunya","og_description":"Actualizaci\u00f3n sobre el cese gradual de la comercializaci\u00f3n de algunas insulinas de Novo Nordisk.","og_url":"https:\/\/adc.cat\/es\/actualidad\/cese-gradual-de-la-comercializacion-de-algunas-insulinas-de-novo-nordisk\/","og_site_name":"ADC \u2013 Associaci\u00f3 de Diabetis de Catalunya","article_publisher":"https:\/\/www.facebook.com\/ADC.CAT\/","article_published_time":"2025-01-29T11:05:01+00:00","article_modified_time":"2025-06-02T12:18:49+00:00","og_image":[{"width":1080,"height":720,"url":"https:\/\/adc.cat\/wp-content\/uploads\/2025\/01\/17.jpg","type":"image\/jpeg"}],"author":"Sandra","twitter_card":"summary_large_image","twitter_creator":"@ADC_CAT","twitter_site":"@ADC_CAT","twitter_misc":{"Escrito por":"Sandra","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/adc.cat\/es\/actualidad\/cese-gradual-de-la-comercializacion-de-algunas-insulinas-de-novo-nordisk\/#article","isPartOf":{"@id":"https:\/\/adc.cat\/es\/actualidad\/cese-gradual-de-la-comercializacion-de-algunas-insulinas-de-novo-nordisk\/"},"author":{"name":"Sandra","@id":"https:\/\/adc.cat\/es\/#\/schema\/person\/c3095eda6e9c2068ff66a789795e0685"},"headline":"Suspensi\u00f3n gradual de algunas insulinas de Novo Nordisk","datePublished":"2025-01-29T11:05:01+00:00","dateModified":"2025-06-02T12:18:49+00:00","mainEntityOfPage":{"@id":"https:\/\/adc.cat\/es\/actualidad\/cese-gradual-de-la-comercializacion-de-algunas-insulinas-de-novo-nordisk\/"},"wordCount":169,"publisher":{"@id":"https:\/\/adc.cat\/es\/#organization"},"image":{"@id":"https:\/\/adc.cat\/es\/actualidad\/cese-gradual-de-la-comercializacion-de-algunas-insulinas-de-novo-nordisk\/#primaryimage"},"thumbnailUrl":"https:\/\/adc.cat\/wp-content\/uploads\/2025\/01\/17.jpg","articleSection":["Actualidad"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/adc.cat\/es\/actualidad\/cese-gradual-de-la-comercializacion-de-algunas-insulinas-de-novo-nordisk\/","url":"https:\/\/adc.cat\/es\/actualidad\/cese-gradual-de-la-comercializacion-de-algunas-insulinas-de-novo-nordisk\/","name":"Suspensi\u00f3n gradual de algunas insulinas de Novo Nordisk - ADC \u2013 Associaci\u00f3 de Diabetis de Catalunya","isPartOf":{"@id":"https:\/\/adc.cat\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/adc.cat\/es\/actualidad\/cese-gradual-de-la-comercializacion-de-algunas-insulinas-de-novo-nordisk\/#primaryimage"},"image":{"@id":"https:\/\/adc.cat\/es\/actualidad\/cese-gradual-de-la-comercializacion-de-algunas-insulinas-de-novo-nordisk\/#primaryimage"},"thumbnailUrl":"https:\/\/adc.cat\/wp-content\/uploads\/2025\/01\/17.jpg","datePublished":"2025-01-29T11:05:01+00:00","dateModified":"2025-06-02T12:18:49+00:00","description":"Actualizaci\u00f3n sobre el cese gradual de la comercializaci\u00f3n de algunas insulinas de Novo Nordisk.","breadcrumb":{"@id":"https:\/\/adc.cat\/es\/actualidad\/cese-gradual-de-la-comercializacion-de-algunas-insulinas-de-novo-nordisk\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/adc.cat\/es\/actualidad\/cese-gradual-de-la-comercializacion-de-algunas-insulinas-de-novo-nordisk\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/adc.cat\/es\/actualidad\/cese-gradual-de-la-comercializacion-de-algunas-insulinas-de-novo-nordisk\/#primaryimage","url":"https:\/\/adc.cat\/wp-content\/uploads\/2025\/01\/17.jpg","contentUrl":"https:\/\/adc.cat\/wp-content\/uploads\/2025\/01\/17.jpg","width":1080,"height":720},{"@type":"BreadcrumbList","@id":"https:\/\/adc.cat\/es\/actualidad\/cese-gradual-de-la-comercializacion-de-algunas-insulinas-de-novo-nordisk\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/adc.cat\/es\/"},{"@type":"ListItem","position":2,"name":"Suspensi\u00f3n gradual de algunas insulinas de Novo Nordisk"}]},{"@type":"WebSite","@id":"https:\/\/adc.cat\/es\/#website","url":"https:\/\/adc.cat\/es\/","name":"ADC \u2013 Associaci\u00f3 de Diabetis de Catalunya","description":"L&#039;ADC representa els pacients amb diabetis de Catalunya. Els nostres objectius: informar, aconsellar, ajudar i defensar les persones amb diabetis i promoure la sensibilitzaci\u00f3 de la resta de la societat","publisher":{"@id":"https:\/\/adc.cat\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/adc.cat\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/adc.cat\/es\/#organization","name":"Associaci\u00f3 de Diabetis de Catalunya","url":"https:\/\/adc.cat\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/adc.cat\/es\/#\/schema\/logo\/image\/","url":"https:\/\/adc.cat\/wp-content\/uploads\/2022\/01\/associacio_de_diabetis_catalunya.png","contentUrl":"https:\/\/adc.cat\/wp-content\/uploads\/2022\/01\/associacio_de_diabetis_catalunya.png","width":512,"height":239,"caption":"Associaci\u00f3 de Diabetis de Catalunya"},"image":{"@id":"https:\/\/adc.cat\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ADC.CAT\/","https:\/\/x.com\/ADC_CAT","https:\/\/www.instagram.com\/adc_cat\/","https:\/\/www.linkedin.com\/company\/associacio-de-diabetis-de-catalunya","https:\/\/www.youtube.com\/channel\/UC7BiJMxG_5sHYUhMAlevAWA"]},{"@type":"Person","@id":"https:\/\/adc.cat\/es\/#\/schema\/person\/c3095eda6e9c2068ff66a789795e0685","name":"Sandra","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/0a992a44e4e0c2d0d7cb96813afd74f2b3b4ba44b154a672987b5285d79bb9c0?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/0a992a44e4e0c2d0d7cb96813afd74f2b3b4ba44b154a672987b5285d79bb9c0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0a992a44e4e0c2d0d7cb96813afd74f2b3b4ba44b154a672987b5285d79bb9c0?s=96&d=mm&r=g","caption":"Sandra"}}]}},"_links":{"self":[{"href":"https:\/\/adc.cat\/es\/wp-json\/wp\/v2\/posts\/48221","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/adc.cat\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/adc.cat\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/adc.cat\/es\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/adc.cat\/es\/wp-json\/wp\/v2\/comments?post=48221"}],"version-history":[{"count":6,"href":"https:\/\/adc.cat\/es\/wp-json\/wp\/v2\/posts\/48221\/revisions"}],"predecessor-version":[{"id":48587,"href":"https:\/\/adc.cat\/es\/wp-json\/wp\/v2\/posts\/48221\/revisions\/48587"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/adc.cat\/es\/wp-json\/wp\/v2\/media\/48572"}],"wp:attachment":[{"href":"https:\/\/adc.cat\/es\/wp-json\/wp\/v2\/media?parent=48221"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/adc.cat\/es\/wp-json\/wp\/v2\/categories?post=48221"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/adc.cat\/es\/wp-json\/wp\/v2\/tags?post=48221"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}